the aid library

LIST OPTIONS

Filter

6122

Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis

World Health Organization WHO (2012) C_WHO

This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re... more

Download (1207)

View PDF (1681)

Toolkit on Mapping Legal, Health, and Social Services Responses to Child Maltreatment

World Health Organization; Lucerne University; Children Research Centre (2015)

The toolkit aims to provide researchers with guidance for improving the quality of studies that use administrative data to better ascertain child maltreatment incidence, response and service delivery. However, these are complex studies to conduct, and the toolkit is not meant to be comprehensive. Re... more

Download (420)

View PDF (798)

Consensus statement on the revised World Health Organization recommendations for BCG vaccination in HIV-infected infants

A. C. Hesseling, M. F. Cotton, C. F. von Reyn, et al. CG Working Group, Child Lung Health Section, International Union Against Tuberculosis and Lung Disease (2008)

Offical Statement INT J TUBERC LUNG DIS 12(12):1376–1379

Download (355)

View PDF (542)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

External Link

Coronavirus disease (COVID-19) update Bangladesh

World Health Organization (WHO), Regional Office for South-East Asia (2021) C_WHO

Download (2654)

View PDF (2469)

National Formulary of India

Ministry of Health and Social Welfare, India (2011) C1

Download (1059)

View PDF (1872)

Training module on malaria control : case management. Guide for Tutors

World Health Organization WHO (2012) C_WHO

Case Management; Guide for Tutors

Download (380)

View PDF (359)

Critères pour lever l’isolement des patients atteints de COVID-19

Organisation Mondiale de la Santé OMS (2020) C_WHO

document d’information scientifique, 17 juin 2020

Download (319)

View PDF (305)

Antibacterial agents in preclinical development: an open access database

World Health Organization WHO (2019) C_WHO

The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens. However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for... more

Download (204)

View PDF (189)

Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols

Kratzel, A.; D. Todt, P. V’kovski, et al. (2020) CC

Emerg Infect Dis. 2020 Jul [date cited]. https://doi.org/10.3201/eid2607.200915 Infection control instructions call for use of alcohol-based hand rub solutions to inactivate severe acute respiratory syndrome coronavirus 2. We determined the virucidal activity of World Health Organization–recommen... more

Download (477)

View PDF (745)

Situation of Maternal and Newborn Health in Urban Slums of Bhubaneswar: Summary Report

Save the Children (2016) C2

Save the Children in collaboration with the Bhubaneswar Municipal Corporation (BMC) and the state National Health Mission (NHM) undertook this study in the urban slums of Bhubaneswar city to generate learnings for designing a city-specific public health approach to improve MNH services for the urban... more

Download (1661)

View PDF (2297)

Recommendations for pharmacy management and the dispensing ofAnti-RetroviralMedicines in Resource-limited settings

FIP Working Group on Pharmacists and HIV-AIDS InternationalPharmaceuticalFederation (2008) CC

Download (513)

View PDF (1031)

Programmatic and Training Brief: Engaging Frontline Community Health Workers in Providing Oral Rapid HIV Testing to Pregnant Women in India

Sarkar A, Mburu G, Shukla S, Behara J, et al. (2016) C1

Download (887)

View PDF (1083)

Integrated Biological and Behavioral Surveillance (IBBS) Survey among People Who Inject Drugs (PWID- Male) in Western to Far Western Terai Highway Districts of Nepal, Round V, 2016

Ministry of Health Nepal; National Centre for AIDS and STD Control (NCASC) (2016) C1

Download (356)

View PDF (532)

Manual on Community-Based Disaster Risk Reduction (Burmese Version)

Myanmar Red Cross Society (2013) C1

Overview:
- Part A is an introductory part which will give you background information about CBDRR in Myanmar. It has a small section about the importance of CBDRR in Myanmar, the stakeholders of CBDRR in Myanmar, as well as an overview about the challenges that are faced when implementing CBDRR... more

Download (241)

View PDF (273)

Role of sterile injection equipment and outreach programmes for injecting drug users

World Health Organization (2012) C_WHO

Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related harm? Is advice on ways to reduce drug related harm safe and effective, using an outreach model of service delivery?